Compare ITRM & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITRM | AQMS |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 20.9M |
| IPO Year | 2018 | 2015 |
| Metric | ITRM | AQMS |
|---|---|---|
| Price | $0.31 | $4.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $9.00 | ★ $12.00 |
| AVG Volume (30 Days) | 497.5K | ★ 736.3K |
| Earning Date | 03-20-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $390,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $193.01 | $550.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.26 | $3.37 |
| 52 Week High | $1.62 | $39.40 |
| Indicator | ITRM | AQMS |
|---|---|---|
| Relative Strength Index (RSI) | 42.44 | 37.83 |
| Support Level | $0.31 | $4.72 |
| Resistance Level | $0.37 | $5.54 |
| Average True Range (ATR) | 0.03 | 0.53 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 9.44 | 6.44 |
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.